Entrepreneurs, Executives, & Eccentrics

Pete O’Heeron on Fibroblasts, Cell Therapy, and Building What Others Overlook

August 3, 2026·37 min
Episode Description from the Publisher

In this episode, FibroBiologics founder and CEO Pete O’Heeron shares how a career spanning hospital administration, medical devices, music, mining, and biotechnology shaped his approach to entrepreneurship. He explains the company’s work with fibroblast cells as a potential therapy for chronic disease and tissue regeneration, including the early research that led him to explore their use in spinal discs. Pete also discusses how he evaluates inventions, tests product demand, builds patent portfolios, and turns early ideas into marketable technologies. Throughout the conversation, he outlines the principles that guide his work: make progress each day, shorten project timelines wherever possible, understand that everyone is in sales, and focus on the patient or product rather than financial results alone.TakeawaysFibroBiologics is developing fibroblast-based cell therapies for chronic disease and tissue regeneration.Pete believes fibroblasts may offer greater stability, easier handling, and stronger therapeutic potential than stem cells.The company began with research into using dermal fibroblasts to regenerate cartilage in spinal discs.Early laboratory and animal studies encouraged Pete to expand the company’s research beyond spinal applications.Pete built his career by moving between fields and learning new industries through direct experience.Hospital administration gave him a broad foundation in medicine, finance, contracts, operations, real estate, and people management.He believes every role includes sales because people must explain, support, and gain approval for their work.His main productivity rule is to move a project forward each day, even when the progress is small.He shortens project timelines by scheduling decisions earlier and asking for deliverables before the proposed deadline.He believes long-term success comes from serving the patient or improving the product, not from chasing financial results alone.Today's guest, Pete O’Heeron, can be found at:Website: https://fibrobiologics.com/LinkedIn: https://www.linkedin.com/in/peteoheeron/Your host, Scott Turman, can be found online at:Website: https://scottturman.com/, https://brightray.com/LinkedIn: https://www.linkedin.com/in/scottturman/IMDb: https://www.imdb.com/name/nm14602682/KeywordsFibroblasts, Cell Therapy, Regenerative Medicine, Chronic Disease, Tissue Regeneration, Stem Cells, Biotechnology, Medical Innovation, Spinal Disc Regeneration, Cartilage Cells, Biologics, Therapeutic Development, Patent Strategy, Clinical Research, Animal Trials, Medical Devices, Surgical Instruments, Hospital Administration, Healthcare Leadership, Entrepreneurship, Product Market Fit, Product Development, Sales, Work Ethic, Project Management, Time Management, Venture Capital, Angel Investors, Mining, Music Industry, Record Labels, Tort Reform, Leadership, Equal Opportunity, Business Strategy, Patient Care

Podzilla Summary coming soon

Sign up to get notified when the full AI-powered summary is ready.

Get Free Summaries →

Free forever for up to 3 podcasts. No credit card required.

Get summaries like this every morning.

Free AI-powered recaps of Entrepreneurs, Executives, & Eccentrics and your other favorite podcasts, delivered to your inbox.

Get Free Summaries →

Free forever for up to 3 podcasts. No credit card required.